Related Experiment Video
Updated: May 5, 2026
06:11
High-definition Transcranial Direct Current Stimulation over Right Dorsolateral Prefrontal Cortex to Enhance Metacognitive Sensitivity
Published on: September 26, 2025
1.2K
Eliciting the implicit: metacognition in Alzheimer's disease
Céline Souchay1, Chris J A Moulin
1a LEAD CNRS UMR 5022, Université de Bourgogne , Dijon , France http://dx.doi.org/10.1080/17588928.2013.853657.
Cognitive Neuroscience
|November 21, 2013
Summary
People with Alzheimer's disease show preserved implicit metacognition, enabling them to regulate study time effectively. However, explicit metacognitive awareness is impaired, highlighting complex cognitive changes.
Area of Science:
- Cognitive Neuroscience
- Neurology
Background:
- Metacognition involves both awareness and control of cognitive processes.
- Alzheimer's disease (AD) significantly impacts cognitive functions, including memory and self-awareness.
Purpose of the Study:
- To investigate the dual nature of metacognition (implicit and explicit) in individuals with Alzheimer's disease.
- To explore how AD affects memory monitoring and control processes.
Main Methods:
- Review of existing literature on metacognition and Alzheimer's disease.
- Analysis of empirical tasks assessing metacognitive performance in AD patients.
Main Results:
- Individuals with AD demonstrate an ability to implicitly regulate study duration, suggesting preserved aspects of metacognition.
- Explicit metacognitive judgments, such as performance predictions, are often impaired in AD.
- The findings reveal a complex pattern of preserved and impaired metacognitive knowledge in Alzheimer's disease.
Conclusions:
- Metacognitive deficits in Alzheimer's disease are multifaceted, involving both intact implicit awareness and impaired explicit monitoring.
- Further research is needed to understand the various dimensions of awareness in AD patients.
- Understanding these nuances is crucial for developing targeted interventions and support strategies.
Related Concept Videos
01:24Implicit Memories
647
Implicit memories, also known as non-declarative memories, are long-term memories that function outside of conscious awareness. These memories influence behavior and skills without explicit knowledge. This type of memory is evident in tasks like playing tennis, snowboarding, and texting. Implicit memory has three subsystems: procedural memory, conditioning, and priming. This type of memory is essential in various activities, from everyday tasks to specialized skills.
One key aspect of implicit...
One key aspect of implicit...
647
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:29Alzheimer Disease l: Introduction
29
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
29
01:23Alzheimer Disease ll: Pathophysiology
42
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
42
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
932
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
932